SENORES PHARMACEUTICALS L Cash Flow Reinvestment Rate

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L cash flow reinvestment rate. SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow Reinvestment Rate of 3.99x as of September 2025, reinvesting Rs966.90 Million (capex Rs966.90 Million ) from operating cash flow of Rs242.20 Million. Explore debt repayment capacity of SENORES PHARMACEUTICALS L to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.99x

(Capex + Investments) / Operating CF

Total Reinvested

Rs966.90 Million

Capex + Investments

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

Cash Flow Reinvestment Rate of SENORES PHARMACEUTICALS L (2026–2026)

Cash flow reinvestment rate of SENORES PHARMACEUTICALS L from 2026 to 2026. Historical reinvestment intensity for SENORES PHARMACEUTICALS L across 1 annual periods. Explore SENORES capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

SENORES PHARMACEUTICALS L Cash Flow Reinvestment Rate by Year (2026–2026)

SENORES PHARMACEUTICALS L cash flow reinvestment rate by year from 2026 to 2026. Year-by-year capital reinvestment analysis for SENORES PHARMACEUTICALS L. For the full cash flow conversion analysis, see SENORES PHARMACEUTICALS L operating cash flow efficiency.

Year	Reinvestment Rate	Total Reinvested (INR)	Operating CF	Capex	YoY Change
2026	6.87x	Rs4.27 Billion	Rs620.50 Million	Rs2.65 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow